{
  "type": "add_node",
  "timestamp": "2025-08-15T02:54:15",
  "processed": false,
  "inputs": {
    "source_article_id": "UE0RKHCKK",
    "status": "rejected",
    "reject_category": "healthcare_policy",
    "reject_failure_cat": "industry_vertical"
  },
  "details": {
    "llm_topic_proposal_raw": {
      "motivation": "The article discusses the implications of Costco's decision not to dispense mifepristone, a key medication for abortion, which is central to ongoing macro-level debates about reproductive health access and its impact on retail and healthcare sectors. This necessitates a new node to analyze the broader market and policy implications surrounding mifepristone access.",
      "id": "mifepristone_access",
      "name": "Mifepristone Access",
      "type": "macro",
      "level": "driver"
    },
    "topic_category": {
      "category": "healthcare_policy",
      "motivation": "Increase access to medication abortion by reducing unnecessary in‑person restrictions, ensuring safe and effective use of mifepristone via telemedicine and mail delivery."
    },
    "relevance_gate": {
      "should_add": false,
      "reason": "Mifepristone is a specific medication (product category), not a macro driver, tradable asset, or macro policy regime; it falls outside the scope of a trading‑focused macro knowledge graph.",
      "confidence": 0.95,
      "failure_category": "industry_vertical"
    }
  },
  "id": "none"
}